DK0682017T3 - Substituerede bicycliske heteroaroylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller - Google Patents
Substituerede bicycliske heteroaroylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel ellerInfo
- Publication number
- DK0682017T3 DK0682017T3 DK95106596T DK95106596T DK0682017T3 DK 0682017 T3 DK0682017 T3 DK 0682017T3 DK 95106596 T DK95106596 T DK 95106596T DK 95106596 T DK95106596 T DK 95106596T DK 0682017 T3 DK0682017 T3 DK 0682017T3
- Authority
- DK
- Denmark
- Prior art keywords
- poly
- drug
- processes
- preparation
- ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4415873A DE4415873A1 (de) | 1994-05-05 | 1994-05-05 | Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0682017T3 true DK0682017T3 (da) | 1999-12-13 |
Family
ID=6517371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95106596T DK0682017T3 (da) | 1994-05-05 | 1995-05-02 | Substituerede bicycliske heteroaroylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller |
Country Status (19)
Country | Link |
---|---|
US (1) | US6093729A (ko) |
EP (1) | EP0682017B1 (ko) |
JP (1) | JP3774771B2 (ko) |
KR (1) | KR950032129A (ko) |
CN (1) | CN1117045A (ko) |
AT (1) | ATE183179T1 (ko) |
AU (1) | AU693861B2 (ko) |
CA (1) | CA2148666A1 (ko) |
DE (2) | DE4415873A1 (ko) |
DK (1) | DK0682017T3 (ko) |
ES (1) | ES2136767T3 (ko) |
FI (1) | FI952117A (ko) |
GR (1) | GR3031539T3 (ko) |
HU (1) | HUT72089A (ko) |
IL (1) | IL113606A0 (ko) |
NO (1) | NO304830B1 (ko) |
NZ (1) | NZ272058A (ko) |
TW (1) | TW429252B (ko) |
ZA (1) | ZA953588B (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5627193A (en) * | 1995-02-09 | 1997-05-06 | Mitsui Toatsu Chemicals, Inc. | Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds |
DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
DE19548812A1 (de) * | 1995-12-27 | 1997-07-03 | Hoechst Ag | Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation |
CA2195697A1 (en) * | 1996-02-02 | 1997-08-03 | Masahumi Kitano | Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof |
DE19621483A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19621482A1 (de) | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
JP3652708B2 (ja) | 1997-03-06 | 2005-05-25 | トーアエイヨー株式会社 | シクロアルカ[b]ピリジン−3−カルボニルグアニジン誘導体、その製造法およびそれを含有する医薬品 |
JP2002502414A (ja) * | 1997-06-02 | 2002-01-22 | 藤沢薬品工業株式会社 | 細胞中のNa▲上+▼/H▲上+▼交換の阻害剤としてのグアニジン誘導体 |
US6350749B1 (en) | 1998-02-20 | 2002-02-26 | Takeda Chemical Industries, Ltd. | Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
US6706732B1 (en) | 1999-06-03 | 2004-03-16 | Takeda Chemical Industries, Ltd. | Nasal preparation of guanidinoimino quinoline derivatives |
EP2617709B8 (en) * | 2003-06-26 | 2022-12-21 | Biotron Limited | Guanidine derivatives as antiviral agents |
CN104370813A (zh) * | 2014-10-22 | 2015-02-25 | 上海大学 | 异喹啉-6-甲醛的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
EP0556673B1 (de) * | 1992-02-15 | 1997-09-17 | Hoechst Aktiengesellschaft | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
CZ284456B6 (cs) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
ATE139526T1 (de) * | 1992-02-15 | 1996-07-15 | Hoechst Ag | 3,5-substituierte benzoylguanidine, mit antiarrythmischer wirkung und inhibierender wirkung auf die proliferationen von zellen |
DK0590455T3 (da) * | 1992-09-28 | 2001-01-22 | Hoechst Ag | Antiarrytmiske og cardioprotektive substiuerede 1(2H)-isoquinoliner, fremgangsmåde til deres fremstilling, lægemiddel indeh |
-
1994
- 1994-05-05 DE DE4415873A patent/DE4415873A1/de not_active Withdrawn
- 1994-09-30 TW TW083109021A patent/TW429252B/zh active
-
1995
- 1995-05-02 JP JP10854795A patent/JP3774771B2/ja not_active Expired - Fee Related
- 1995-05-02 AT AT95106596T patent/ATE183179T1/de not_active IP Right Cessation
- 1995-05-02 DK DK95106596T patent/DK0682017T3/da active
- 1995-05-02 EP EP95106596A patent/EP0682017B1/de not_active Expired - Lifetime
- 1995-05-02 ES ES95106596T patent/ES2136767T3/es not_active Expired - Lifetime
- 1995-05-02 DE DE59506564T patent/DE59506564D1/de not_active Expired - Lifetime
- 1995-05-03 CN CN95105390A patent/CN1117045A/zh active Pending
- 1995-05-03 FI FI952117A patent/FI952117A/fi unknown
- 1995-05-03 AU AU17861/95A patent/AU693861B2/en not_active Ceased
- 1995-05-03 IL IL11360695A patent/IL113606A0/xx unknown
- 1995-05-03 NZ NZ272058A patent/NZ272058A/en unknown
- 1995-05-04 NO NO951736A patent/NO304830B1/no not_active IP Right Cessation
- 1995-05-04 HU HU9501285A patent/HUT72089A/hu unknown
- 1995-05-04 KR KR1019950011160A patent/KR950032129A/ko not_active Application Discontinuation
- 1995-05-04 ZA ZA953588A patent/ZA953588B/xx unknown
- 1995-05-04 CA CA002148666A patent/CA2148666A1/en not_active Abandoned
-
1998
- 1998-11-18 US US09/195,098 patent/US6093729A/en not_active Expired - Lifetime
-
1999
- 1999-10-15 GR GR990402626T patent/GR3031539T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR950032129A (ko) | 1995-12-20 |
FI952117A (fi) | 1995-11-06 |
HUT72089A (en) | 1996-03-28 |
EP0682017A1 (de) | 1995-11-15 |
NZ272058A (en) | 1996-02-27 |
JPH0841028A (ja) | 1996-02-13 |
NO304830B1 (no) | 1999-02-22 |
AU693861B2 (en) | 1998-07-09 |
US6093729A (en) | 2000-07-25 |
ATE183179T1 (de) | 1999-08-15 |
CN1117045A (zh) | 1996-02-21 |
ZA953588B (en) | 1996-06-16 |
TW429252B (en) | 2001-04-11 |
FI952117A0 (fi) | 1995-05-03 |
AU1786195A (en) | 1995-11-16 |
NO951736L (no) | 1995-11-06 |
JP3774771B2 (ja) | 2006-05-17 |
DE59506564D1 (de) | 1999-09-16 |
IL113606A0 (en) | 1995-08-31 |
CA2148666A1 (en) | 1995-11-06 |
ES2136767T3 (es) | 1999-12-01 |
DE4415873A1 (de) | 1995-11-09 |
NO951736D0 (no) | 1995-05-04 |
GR3031539T3 (en) | 2000-01-31 |
EP0682017B1 (de) | 1999-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0682017T3 (da) | Substituerede bicycliske heteroaroylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller | |
ES2079534T3 (es) | Derivados de polietilenglicol, sus peptidos modificados, metodos para producirlos y uso de los peptidos modificados. | |
FI925615A0 (fi) | Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening | |
EE03178B1 (et) | Kondenseerunud bitsüklilist tuuma sisaldavad ühendid, nende vaheproduktid, valmistamismeetodid ja farmatseutilised kompositsioonid | |
DK160981C (da) | Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater | |
FI920023A0 (fi) | Heteroarylpiperazinfoereningar som antipsykotiska aemnen. | |
DK160788A (da) | 2-oen-phenyl(eller phenoxy)alkyl-n-methyl-aminoaaindan-forbindelser, anvendelse af sulfonamido-derivater blandt disse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende sulfonamiderne | |
DK0973763T3 (da) | Hidtil ukendte 2-(iminomethyl)aminophenylderivater, fremstilling af disse, anvendelse af disse i egenskab af lægemidler og farmaceutiske præparater indeholdende disse | |
DK0700380T3 (da) | N-Alkylthiopolyaminderivater som radioprotektive midler | |
DK0532595T3 (da) | Farmakologisk anvendelse af visse cystinderivater | |
DK50086A (da) | 3-phenyl-tetrahydropyridinderivater | |
DK431489D0 (da) | Lipoprotein i (ompi) af pseudomonas aeruginosa, dets fremstilling og anvendelse | |
MX9301298A (es) | Seudopeptidos, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
DK160688A (da) | Ae5-alkylsulfonamido-2-(n-alkylsulfonamidoheterocyclylmethyl-n-methyl-amino)indan-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende sulfonamiderne samt 2-(n-methylamino)indan-forbindelser, der er nyttige som mellemprodukterae | |
PT861837E (pt) | Novos compostos de 2-amino-indano processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
ES271812Y (es) | Parte de construccion para la ereccion de edificaciones o partes de las mismas. | |
DK437287D0 (da) | 2,3-dihydrofuranderivater, deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af tetrahydrofuranderivater | |
BR9504489A (pt) | Derivados de benzoilguanidinas processo para sua preparaçao processo para a produçao de preparados farmacêuticos preparado farmacêutico e uso | |
DK160588D0 (da) | Ae3-heterocyclylmethyl-1,2,4,5-tetrahydro-3h-3-benzazepin-forbindelser, anvendelse af sulfonamido-derivater blandt disse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende sulfonamiderne | |
DK0553792T3 (da) | Fremgangsmåde til fremstilling af dinatriumsalt,hemiheptahydratet af cefriaxon | |
DK0457215T3 (da) | 3-deamino-4-desoxy-4-amino-8-fluoranthracycliner samt fremgangsmåder til fremstilling deraf | |
FI934468A0 (fi) | Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter | |
DK0516802T3 (da) | Nye svovlholdige forbindelser, deres fremstilling og deres anvendelse som additiver til smøreolier | |
DE3160824D1 (en) | Use of 4-thioparabanic acid derivatives as herbicides | |
ES544063A0 (es) | Procedimiento para la preparacion de la n-(2-(((5-(dimetila-mino)metil-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1- etilendiamina |